The consensus group found multiple faults with the term NAFLD; these include: i) NAFLD is
a disease of exclusion instead of being defined by inclusion, ii) NAFLD is a vastly …

Background and aims. There is evidence for low-grade inflammation in the pathophysiology
of post-infectious irritable bowel syndrome (IBS). We assessed the degree of subclinical …

Background Transarterial-chemo-embolization (TACE) is used for palliation of unresectable
hepatocellular carcinoma (HCC). We studied the tolerability of TACE in a cohort of patients …

Background There is no recent data addressing the long term survival of cirrhosis patients
without transplantation, but with the availability of optimal pharmacological and endoscopic …

AIM: To determine if inflammatory bowel disease (IBD) is a risk factor for osteoporosis in adult
Sri Lankans. METHODS: We identified eligible subjects from among consecutive patients …

Introduction. Available evidence for routine terminal ileoscopy during colonoscopy is equivocal.
We investigated the place of routine terminal ileoscopy and biopsy during colonoscopy, …

Background Alpha-fetoprotein (AFP) is a biomarker for hepatocellular carcinoma (HCC). The
significance of pre-treatment AFP (pt-AFP) in non-viral HCC (nvHCC) is not clear. Methods …

Introduction Identification of advanced hepatic fibrosis in non-alcoholic fatty liver disease (NAFLD)
is important as this may progress to cirrhosis and hepatocellular carcinoma. The risk …

Methods Thirty mild, stable asthmatics and 30 healthy controls underwent real-time
ultrasonography and 1 hour pre-and post-prandial cutaneous electrogastrography, following a test …

Non-alcoholic fatty liver disease (NAFLD) seems to recur in at least one third of patients
transplanted for non-alcoholic steatohepatitis (NASH)-related cirrhosis. While, NASH recurrence …